Heather Hancock, MD
Ophthalmology · Jackson, MSNPI 1821120072
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $34,050 of the $38,597 with a category attached, or 88.2%. Mallinckrodt Hospital Products Inc. accounts for 93.1% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $21,724, more than ten times the $145 reported in 2019. Among ophthalmology clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 180 payments — averaging $214.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mallinckrodt Hospital Products Inc.$36K
- AbbVie$626
- Alcon$432
- Apellis Pharmaceuticals, Inc.$344
- Regeneron Healthcare Solutions, Inc.$338
- ANI Pharmaceuticals, Inc.$207
- plus $712 from 9 others
What the payments were for
- Speaking & faculty fees$34,05088%
- Travel & lodging$1330%
- Food & beverage$4,36911%
- Gifts$450%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 89 | $35,938 |
| AbbVie(2 entities) | 32 | $626 |
| Alcon | 4 | $432 |
| Apellis Pharmaceuticals, Inc. | 13 | $344 |
| Regeneron Healthcare Solutions, Inc. | 11 | $338 |
| ANI Pharmaceuticals, Inc. | 9 | $207 |
| Inspire Medical Systems, Inc. | 2 | $192 |
| Regeneron | 1 | $98 |
| Alimera Sciences, Inc. | 4 | $88 |
| Glaukos Corporation | 1 | $81 |
| Astellas Pharma US Inc | 4 | $81 |
| Genentech USA, Inc. | 4 | $67 |
| Ocular Therapeutix, Inc. | 2 | $38 |
| Boston Scientific | 2 | $34 |
| Novartis | 2 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$38,597 in reported general payments places this provider in the 95th percentile of 150 ophthalmology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 390 | $10,585 |
| Ketorolac Tromethamine | 491 | $7,509 |
| Difluprednate | 16 | $2,128 |
| Eplerenone | 27 | $1,782 |
| Brimonidine Tartrate | 229 | $1,333 |
| Travoprost | 11 | $1,331 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 104 | $1,210 |
| Latanoprost | 140 | $865 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 66 | $695 |
| MoxifloxacinMoxifloxacin Hcl | 29 | $517 |
| Doxycycline Hyclate | 16 | $339 |
| Dorzolamide Hcl | 23 | $276 |
| ErythromycinErythromycin Base | 24 | $240 |
| Timolol Maleate | 29 | $186 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Jackson
- Mark KoskoJackson$27K
- John ShippJackson$10K
- Kirk JeffreysJackson$9K
- Lee JonesJackson$8K
- Albert WilliamsJackson$6K
- Younghyun OhJackson$5K
- Farrah NewmanJackson$4K
- Taylor SmithJackson$4K
- Cassie ConfaitJackson$4K
- Curtis WhittingtonJackson$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.